ETF Managers Group’s Galmed Pharmaceuticals GLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-404
| Closed | -$254K | – | 628 |
|
|
2020
Q3 | $254K | Buy |
404
+32
| +9% | +$20.1K | 0.01% | 547 |
|
|
2020
Q2 | $324K | Buy |
372
+141
| +61% | +$123K | 0.01% | 370 |
|
|
2020
Q1 | $143K | Buy |
231
+21
| +10% | +$13K | 0.01% | 500 |
|
|
2019
Q4 | $216K | Sell |
210
-50
| -19% | -$51.4K | 0.01% | 511 |
|
|
2019
Q3 | $228K | Buy |
260
+9
| +4% | +$7.89K | 0.01% | 348 |
|
|
2019
Q2 | $282K | Buy |
251
+64
| +34% | +$71.9K | 0.01% | 292 |
|
|
2019
Q1 | $274K | Sell |
187
-6
| -3% | -$8.79K | 0.01% | 269 |
|
|
2018
Q4 | $237K | Buy |
193
+64
| +50% | +$78.6K | 0.01% | 282 |
|
|
2018
Q3 | $316K | Buy |
+129
| New | +$316K | 0.01% | 231 |
|
|
2018
Q2 | – | Sell |
-84
| Closed | -$76K | – | 533 |
|
|
2018
Q1 | $76K | Buy |
84
+14
| +20% | +$12.7K | ﹤0.01% | 401 |
|
|
2017
Q4 | $119K | Buy |
+70
| New | +$119K | 0.01% | 225 |
|